Dow Down 0.25% Nasdaq Down 0.26%

Nektar Therapeutics (NKTR)

-NasdaqGS
14.31 Up 0.03(0.21%) 4:00PM EDT
Prev Close:14.28
Open:14.20
Bid:13.00 x 100
Ask:14.75 x 1700
1y Target Est:16.78
Beta:1.37
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:14.13 - 14.58
52wk Range:8.87 - 15.34
Volume:755,232
Avg Vol (3m):1,149,000
Market Cap:1.82B
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NKTR

Comparison

Symbol% ChgMkt Cap
NKTRUp 0.21%1.82B
BMYUp 0.58%83.79B
ENZNUp 6.85%68.84M
GSKUp 0.41%117.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Sep-14) :0.39
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback